J&J’s Erleada Gives Chase To Xtandi For Non-Metastatic Prostate Cancer With Approval In Europe

 
• By Jo Shorthouse
  
SpartanHelmet
Data from Janssen's SPARTAN trial meant EU approval for Erleada • Source: Shutterstock

More from Anticancer

More from Therapy Areas